Almost 85% of overcharged amount claimed by NPPA yet to be recovered
New Delhi: India’s drug price monitoring and enforcing authority, the National Pharmaceutical Pricing Authority (NPPA), has almost 85 per cent of the amount it demanded from the pharma industry on…
Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide
Mumbai: Global pharma major Lupin Limited has announced that it has entered into an exclusive License, Supply and Distribution agreement with Gan & Lee Pharmaceuticals, headquartered in China, for a novel…
Rs 700-crore cough syrup racket: UP drug regulator seeks stricter supply chain rules
The FSDA has sent proposals to the state and central govts after teams scrutinised purchase and sale records of medicine wholesale traders during inspections in Ranchi, Delhi, and Lucknow and…
Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru
The Konkan division of Maharashtra ANTF raided three different locations in Bengaluru, during which the drug manufacturing units were busted. BENGALURU: While the state government is aiming to make Karnataka…
‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA
New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…
Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma
New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…
National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013,…
Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US
Taro Pharmaceutical, a subsidiary of Sun Pharmaceutical, has initiated a recall of over 17,000 units of an antifungal shampoo in the United States after manufacturing issues were flagged by the…
Strides Pharma Science arm New York facility gets 4 USFDA observations
Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection with four observations at the Formulations Facility of Strides Pharma Inc. USA (SPI),…
















